Back

The long-term outcome of pulmonary vein isolation in paroxysmal atrial fibrillation is significantly influenced by diabetes mellitus in general as well as by an antidiabetic therapy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Outcomes after catheter ablation for atrial fibrillation: impact of comorbidities and ablation technique Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Jonathan Dieter Reichl

Munich (Germany)

5 More presentations in this session

Presentation thumbnail
The association of obesity and in-hospital outcomes among patients undergoing ablation for atrial fibrillation: a propensity-score matched analysis
Doctor S. Shoar (Largo, US)
Abstract Slides Video
Presentation thumbnail
Procedural outcomes of fluoroscopy-less catheter ablation for atrial fibrillation
Doctor A. Alfraih (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Single versus double transseptal puncture for pulmonary vein isolation with radiofrequency catheter ablation for atrial fibrillation - insights from "Go for Zero Fluoroscopy" registry
Doctor D. Miskowiec (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Effects of baroreceptor reflex modification on efficacy of ablation for atrial fibrillation
Doctor A. Zuk (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Prevalance of incessant form of atrial fibrillation by superior vena cava (svc) firing: simplified svc and sinus node mapping(sss map) to avoid sinus node injury.
Doctor T. Miyata (Otsu, Shiga, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes after catheter ablation for atrial fibrillation: impact of comorbidities and ablation technique

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prevalence of diabetes mellitus diminished the efficacy of additional ablation following pulmonary vein isolation: a sub-analysis of the EARNEST-PVI trial
thumbnail
Congress Presentation
Long-term prognosis in patients undergoing atrial fibrillation ablation
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitors are more effective than dipeptidyl peptidase 4 inhibitors in preventing mid-term recurrence after atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources